The Wnt inhibitor secreted Frizzled-Related Protein 1 (sFRP1) promotes human Th17 differentiation

European Journal of Immunology

Volumn 42, Issue 10, 2012, Pages 2564-2573

  Lee, Yoon Sook ^a   Lee, Kyoo A ^a   Yoon, Hae Bom ^a   Yoo, Seung Ah ^c   Park, Young Woo ^d   Chung, Yeonseok ^e   Kim, Wan Uk ^c   Kang, Chang Yuil ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Differentiation; Secreted Frizzled Related Protein 1; Th17 cells; Wnt

Indexed keywords

INTERLEUKIN 17; SECRETED FRIZZLED RELATED PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IN VITRO STUDY; MEMORY T LYMPHOCYTE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TH17 CELL; WNT SIGNALING PATHWAY;

ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-17; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SMAD2 PROTEIN; SYNOVIAL MEMBRANE; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84867211734     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242445     Document Type: Article

References (49)

1. Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y. et al., Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008. 452: 773-776.
2. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 cells. Annu. Rev. Immunol. 2009. 27: 485-517.
3. Miossec, P., Korn, T. and Kuchroo, V. K., Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 2009. 361: 888-898.
4. Iwakura, Y., Ishigame, H., Saijo, S. and Nakae, S., Functional specialization of interleukin-17 family members. Immunity 2011. 34: 149-162.
5. Manel, N., Unutmaz, D. and Littman, D. R., The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 2008. 9: 641-649.
6. Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupe, P., Barillot, E. and Soumelis, V., A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 2008. 9: 650-657.
7. Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K. et al., IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008. 454: 350-352.
8. van Amerongen, R. and Nusse, R., Towards an integrated view of Wnt signaling in development. Development 2009. 136: 3205-3214.
9. Reya, T. and Clevers, H., Wnt signalling in stem cells and cancer. Nature 2005. 434: 843-850.
10. Angers, S. and Moon, R. T., Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 2009. 10: 468-477.
11. Kawano, Y. and Kypta, R., Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003. 116: 2627-2634.
12. Nathan, E. and Tzahor, E., sFRPs: a declaration of (Wnt) independence. Nat. Cell Biol. 2009. 11: 13.
13. Esteve, P. and Bovolenta, P., The advantages and disadvantages of sfrp1 and sfrp2 expression in pathological events. Tohoku J. Exp. Med. 2010. 221: 11-17.
14. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E. and Lopez-Rios, J., Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci. 2008. 121: 737-746.
15. Staal, F. J., Luis, T. C. and Tiemessen, M. M., WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 2008. 8: 581-593.
16. Gattinoni, L., Ji, Y. and Restifo, N. P., Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy. Clin. Cancer Res. 2010. 16: 4695-4701.
17. Wu, B., Crampton, S. P. and Hughes, C. C., Wnt signaling induces matrix metalloproteinase expression and regulates T-cell transmigration. Immunity 2007. 26: 227-239.
18. Notani, D., Gottimukkala, K. P., Jayani, R. S., Limaye, A. S., Damle, M. V., Mehta, S., Purbey, P. K. et al., Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010. 8: e1000296.
19. Yu, Q., Sharma, A., Oh, S. Y., Moon, H. G., Hossain, M. Z., Salay, T. M., Leeds, K. E. et al., T-cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat. Immunol. 2009. 10: 992-999.
20. Ding, Y., Shen, S., Lino, A. C., Curotto de Lafaille, M. A. and Lafaille, J. J., Beta-catenin stabilization extends regulatory T-cell survival and induces anergy in nonregulatory T cells. Nat. Med. 2008. 14: 162-169.
21. Yu, Q., Sharma, A., Ghosh, A. and Sen, J. M., T-cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis. J. Immunol. 2011. 186: 3946-3952.
22. Jian, M. R. W., Xianfeng, F., Yan, D. and Zuoming, S., Critical role of TCF-1 in repression of the IL-17 gene. PloS One 2011. 6: e24768.
23. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S. et al., IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999. 103: 1345-1352.
24. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H. and Maslinski, W., High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 2000. 164: 2832-2838.
25. Lee, W. W., Kang, S. W., Choi, J., Lee, S. H., Shah, K., Eynon, E. E., Flavell, R. A. et al., Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 2010. 115: 530-540.
26. Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L. et al., Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009. 30: 576-587.
27. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
28. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
29. Zhang, Y. E., Non-Smad pathways in TGF-beta signaling. Cell Res. 2009. 19: 128-139.
30. Takimoto, T., Wakabayashi, Y., Sekiya, T., Inoue, N., Morita, R., Ichiyama, K., Takahashi, R. et al., Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 2010. 185: 842-855.
31. Martinez, G. J., Zhang, Z., Reynolds, J. M., Tanaka, S., Chung, Y., Liu, T., Robertson, E. et al., Smad2 positively regulates the generation of Th17 cells. J. Biol. Chem. 2010. 285: 29039-29043.
32. Malhotra, N., Robertson, E. and Kang, J., SMAD2 is essential for TGF beta-mediated Th17 cell generation. J. Biol. Chem. 2010. 285: 29044-29048.
33. Yang, X. P., Ghoreschi, K., Steward-Tharp, S. M., Rodriguez-Canales, J., Zhu, J., Grainger, J. R., Hirahara, K. et al., Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 2011. 12: 247-254.
34. Sha, Y. and Markovic-Plese, S., A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases. Self Nonself 2011. 2: 35-42.
35. Guo, X. and Wang, X. F., Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009. 19: 71-88.
36. Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P. et al., Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 2009. 66: 390-402.
37. Bodine, P. V., Zhao, W., Kharode, Y. P., Bex, F. J., Lambert, A. J., Goad, M. B., Gaur, T. et al., The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 2004. 18: 1222-1237.
38. Bodine, P. V., Stauffer, B., Ponce-de-Leon, H., Bhat, R. A., Mangine, A., Seestaller-Wehr, L. M., Moran, R. A. et al., A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. Bone 2009. 44: 1063-1068.
39. Li, C. H. and Amar, S., Inhibition of SFRP1 reduces severity of periodontitis. J. Dent. Res. 2007. 86: 873-877.
40. Daoussis, D., Andonopoulos, A. P. and Liossis, S. N., Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Semin. Arthritis Rheum. 2010. 39: 369-383.
41. Ijiri, K., Nagayoshi, R., Matsushita, N., Tsuruga, H., Taniguchi, N., Gushi, A., Sakakima, H. et al., Differential expression patterns of secreted frizzled related protein genes in synovial cells from patients with arthritis. J. Rheumatol. 2002. 29: 2266-2270.
42. Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S. and Dayer, J. M., Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008. 112: 3696-3703.
43. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S. et al., Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 2009. 206: 535-548.
44. Liu, X. H., Kirschenbaum, A., Weinstein, B. M., Zaidi, M., Yao, S. and Levine, A. C., Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells. Biochem. Biophys. Res. Commun. 2010. 394: 715-720.
45. Lubberts, E., Th17 cytokines and arthritis. Semin. Immunopathol. 2010. 32: 43-53.
46. Chen, G., Zhang, X., Li, R., Fang, L., Niu, X., Zheng, Y., He, D. et al., Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritis. Arthritis Rheum. 2010. 62: 2900-2908.
47. Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., Melendez, A. J. et al., Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 2010. 184: 3336-3340.
48. Dahl, E., Wiesmann, F., Woenckhaus, M., Stoehr, R., Wild, P. J., Veeck, J., Knuchel, R. et al., Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Oncogene 2007. 26: 5680-5691.
49. Zou, W. and Restifo, N. P., T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 2010. 10: 248-256.